Integrating Cutting-Edge Technologies, Including Multi-omics & AI-Driven Data to Advance Potent Personalized TCR-Based Therapies Highlights:
- Proficient in silico identification of patient-specific TCRs offers great potential to treat a broad patient population
- Improve algorithm performance to select clinical-relevant TCRs through integration of multi-omics data
- Leverage AI to predict TCR-pMHC folding structures to guide TCR specificity and enhance target diversity